Skip to content

Drug interactions

Mirabegron + Pitolisant

Severity: Moderate

Mirabegron and Pitolisant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pitolisant is metabolized by CYP2D6 and CYP3A4, so CYP2D6 inhibition by mirabegron can raise pitolisant levels. This may increase QT prolongation risk and adverse effects such as insomnia, anxiety and nausea.

What this interaction means in plain words

Mirabegron and Pitolisant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mirabegron belongs to Genitourinary; Pitolisant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Mirabegron inhibits CYP2D6, decreasing pitolisant clearance.

What to do

Consider the labeled pitolisant dose reduction when CYP2D6 inhibitors are added, and monitor for adverse effects and QT prolongation in at-risk patients.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mirabegron and Pitolisant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mirabegron with Pitolisant?

MediHelp rates the interaction as moderate. Mirabegron and Pitolisant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pitolisant is metabolized by CYP2D6 and CYP3A4, so CYP2D6 inhibition by mirabegron can raise pitolisant levels. This may increase QT prolongation risk and adverse effects such as insomnia, anxiety and nausea.

How serious is the interaction between Mirabegron and Pitolisant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider the labeled pitolisant dose reduction when CYP2D6 inhibitors are added, and monitor for adverse effects and QT prolongation in at-risk patients.

What other medicines interact with Mirabegron?

MediHelp also lists interactions of Mirabegron with, for example, Digoxin, Flecainide, Propafenone. The full list is on the Mirabegron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in